Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Alternative treatments show promise for hair growth beyond traditional methods.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Severe hair loss may worsen with skin condition, suggesting treating the skin might help.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

Stopping tight hairstyles can prevent and reduce traction alopecia.

Bitemporal alopecia often occurs with other hair conditions and can help predict and monitor these issues.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Some breast cancer chemotherapy can cause permanent hair loss.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Minoxidil may help hair regrowth in traction alopecia, but changing hair habits is the main treatment.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.